Clinical Trials Browser

Recruiting × Breast Neoplasms × tislelizumab × Clear all

NCT06471673 2024-08-26

A Study of BRIA-OTS Cellular Immunotherapy in Metastatic Recurrent Breast Cancer

Phase 1/2 Recruiting

Breast Neoplasms